" />
Factor VIII von Willebrand factor.ristocetin cofactor given:ACnc:Pt:Dose:Qn:FVIII
dosing - CISMeF
Factor VIII von Willebrand factor.ristocetin cofactor given:ACnc:Pt:Dose:Qn:FVIII
dosingLOINC code
Preferred Label : Factor VIII von Willebrand factor.ristocetin cofactor given:ACnc:Pt:Dose:Qn:FVIII
dosing;
LOINC status : ACTIVE;
LOINC display name : Factor VIII von Willebrand factor (vWf) ristocetin cofactor given FVIII dosing Qn
(Dose);
LOINC long common name : Factor VIII von Willebrand factor (vWf) ristocetin cofactor given [Units/volume] by
FVIII dosing;
LOINC short name : FVIII vWf:RCo Gvn Dose FVIII dose-aCnc;
LOINC description : The amount of factor VIII (FVIII) and Von Willebrand factor.ristocetin cofactor (vWF:RCo)
complex given based on FVIII dosing for patients with hemophilia A. For dosing based
on vWF for patients with Von Willebrand disease (VWD), see [LOINC: 77725-0]. This
term was created for, but not limited in use to, Humate-P. According to the package
insert provided by the submitter, Humate-P is an antihemophilic factor/von Willebrand
factor complex approved to treat and prevent bleeding in adult patients with hemophilia
A and also to treat spontaneous or trauma-induced bleeding episodes as well as prevent
excessive bleeding during and after surgery in adults and children with von Willebrand
disease (VWD).;
Has component